Search alternatives:
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1741
-
1742
-
1743
-
1744
Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i>
Published 2025“…Mouse EAC cells showed a decrease in cell viability starting from 250 µM at 24h of treatment. …”
-
1745
-
1746
-
1747
-
1748
-
1749
-
1750
Heart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis
Published 2018“…Levels of blood glucose and HbA1c were associated with several HRV parameters, as well as Time from diagnosis of T2DM</p><p>Conclusions</p><p>T2DM was associated with an overall decrease in the HRV of T2DM patients. …”
-
1751
-
1752
-
1753
-
1754
TEMPO-Oxidized Microcrystalline Cellulose for Rapid Adsorption of Ammonium
Published 2022“…Despite a slight decrease in adsorption performance, the material can be regenerated and applied in a real water sample. …”
-
1755
-
1756
-
1757
Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria
Published 2014“…Unadjusted and multivariable analyses of eGFR association with log-transformed lipid parameters in incremental linear and logistic regression models (with eGFR 90 mL/min/1.73 m<sup>2</sup> as a cut-point) were performed.</p><p>Results</p><p>Mild GFR impairment (eGFR 60–90 mL/min/1.73 m<sup>2</sup>, median urinary ACR 5.25 mg/g) was associated with higher log-transformed Lp(a) values (OR 1.17, p = 0.005) and with clinically atherogenic Lp(a) levels above 30 mg/dL (OR 1.35, p = 0.013) even after full adjustment for demographics, medications, metabolic parameters, and albuminuria. …”
-
1758
-
1759
-
1760